ONCOLOGY

Find the latest news within oncology here

News from oncology

Treatment Timing Impacts Survival in Limited Stage Small Cell Lung Cancer

April 2025 / Miriam Grønberg

Lung cancer

P-VERIFY: Kattava tosielämän kokonaiselossaolon (OS) vertaileva analyysi CDK4/6-estäjistä yhdessä aromataasi-inhibiittorin kanssa HR+/HER2- metastasoituneessa rintasyövässä

April 2025 / Pfizer

Breast cancer

Perhaps a New Treatment Option for Patients with Intermediate Hepatocellular Carcinoma

November 2024 / Josep M. Llovet

ESMO24 Livercancer

Oncology • Meet the experts

Get access

ASCO GU 2025

We met leading experts
Get their insight into current studies and new knowledge in oncology

Access full coverage

Read the latest magazine

Oncology / Hematology • No. 17 • 2024

Second-Line Treatment of mRCC – Data Support the Choice of Cabozantinib Monotherapy
ESMO 2024 – Highlights
EHA 2024 – A Danish Late-Breaking Abstract Presented

Get access

Bladder Cancer Treatment Advancements: Key Findings and Progress

February 2025 / Oncology / Thomas Powles

Bone Pain as a Key Prognostic Indicator in Castration-Sensitive Prostate Cancer

February 2025 / Oncology / Deniz Tural / Jan Andreasen

Real-Life Data Confirms Avelumab Maintenance Benefits in Metastatic Urothelial Carcinoma

February 2025 / Oncology / Deniz Tural / Jan Andreasen

Cabozantinib Real-World Effectiveness in the Second-Line Setting of Metastatic Renal Cell Carcinoma

February 2025 / Oncology / Martin Zarba / Jan Andreasen

Real World Longer-Term Follow-Up Data Confirms the Effectiveness and Safety of Avelumab 1st Line Maintenance Treatment of Low-Burden Urothelial Cancer

February 2025 / Oncology / Philippe Barthelemy

Se oversigt

*BestPractice Nordic maintains a continuous dialogue with the Nordic Advisory Editorial Panel. This panel aids in proposing editorial themes, bringing attention to new guidelines, essays, relevant clinical issues, and updates from national and international congresses. Please note that the advisory editorial panel is NOT accountable for the content published by BestPractice Nordic. All content undergoes approval by the author.

Follow news from congresses

See all events

Onkologiapäivät

We cover the Onkologiapäivät 2023 and will give you the latest news within oncology I 7.-8. September 2023

Go to Onkologiapäivät

Fredrik Schjesvold: Bridging Science and Clinical Innovation

March 2025 / Hematology / Jan Andreasen

Advancing Myeloma Research and Treatment: An Interview with Fredrik Schjesvold

March 2025 / Hematology / Fredrik Schjesvold / Jan Andreasen

Liposomal Daunorubicin + Cytarabine: Enhanced Synergistic Antineoplastic Effect in AML Treatment

March 2025 / Hematology / Andrea Lenartova / Jan Andreasen

Pulmonary Diseases in Patients with Classical Hodgkin Lymphoma

February 2025 / Hematology / Julie Haugaard Vandtved

The Aquila Study Strongly Supports the Benefit of Early Intervention with Daratumumab Monotherapy in Patients with High-Risk Smoldering Multiple Myeloma

December 2024 / Hematology / Jan Andreasen

Se oversigt

ASH24: Disease-Modifying Therapies Remain Underused in Sickle Cell Disease in USA

ASH24

December 2024 / Jan Andreasen

Cookie	Duration	Description
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, camapign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assigns a randoly generated number to identify unique visitors.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.

Find the latest news within oncology here

News from oncology

Treatment Timing Impacts Survival in Limited Stage Small Cell Lung Cancer

P-VERIFY: Kattava tosielämän kokonaiselossaolon (OS) vertaileva analyysi CDK4/6-estäjistä yhdessä aromataasi-inhibiittorin kanssa HR+/HER2- metastasoituneessa rintasyövässä

Perhaps a New Treatment Option for Patients with Intermediate Hepatocellular Carcinoma

Oncology • Meet the experts

ASCO GU 2025

Read the latest magazine

Oncology / Hematology • No. 17 • 2024

Bladder Cancer Treatment Advancements: Key Findings and Progress

Bone Pain as a Key Prognostic Indicator in Castration-Sensitive Prostate Cancer

Real-Life Data Confirms Avelumab Maintenance Benefits in Metastatic Urothelial Carcinoma

Cabozantinib Real-World Effectiveness in the Second-Line Setting of Metastatic Renal Cell Carcinoma

Real World Longer-Term Follow-Up Data Confirms the Effectiveness and Safety of Avelumab 1st Line Maintenance Treatment of Low-Burden Urothelial Cancer

Follow news from congresses

Breast Cancer: The Prognostic Value of Tumor-Infiltrating Lymphocytes

Prehabilitation: Making Cancer Patients Fit for Surgery and Speeding Recovery

Abemaciclib Shows Significant Benefit for HR-Positive HER2-Negative Patients with Advanced Breast Cancer

MRI-Based AI Can Detect Responsive Treatment of Breast Cancer After Three Weeks of Therapy

Maximizing the Tolerability of Enfortumab Vedotin + Pembrolizumab – The Upcoming New Standard Treatment for Advanced Bladder Cancer

ASCO 2025: Groundbreaking Data in Bladder and Prostate Cancers

LBA 18: Improvement in Survival with the Addition of Talazoparib to First-Line Enzalutamide Treatment in RR-Deficient mCRPC Patients

LBA Nordic Study: Low-Dose Aspirin Reduces Recurrence in Colorectal Cancer Patients with PI3K Pathway Mutations

ASCO GI 2025: Danish Study Highlights Efficacy and Safety of Single-Cycle Neoadjuvant Pembrolizumab for Localized dMMR Colon Cancer

ASCO GI 2025: Everolimus and Lanreotide Combo as a Breakthrough for Gastroenteropancreatic Neuroendocrine Tumors

Onkologiapäivät

Fredrik Schjesvold: Bridging Science and Clinical Innovation

Advancing Myeloma Research and Treatment: An Interview with Fredrik Schjesvold

Liposomal Daunorubicin + Cytarabine: Enhanced Synergistic Antineoplastic Effect in AML Treatment

Pulmonary Diseases in Patients with Classical Hodgkin Lymphoma

The Aquila Study Strongly Supports the Benefit of Early Intervention with Daratumumab Monotherapy in Patients with High-Risk Smoldering Multiple Myeloma

ASH24: Disease-Modifying Therapies Remain Underused in Sickle Cell Disease in USA

Name & work area

Find the latest news within oncology here

News from oncology

Oncology • Meet the experts

ASCO GU 2025

Read the latest magazine

Oncology / Hematology • No. 17 • 2024

Bladder Cancer Treatment Advancements: Key Findings and Progress

Bone Pain as a Key Prognostic Indicator in Castration-Sensitive Prostate Cancer

Real-Life Data Confirms Avelumab Maintenance Benefits in Metastatic Urothelial Carcinoma

Cabozantinib Real-World Effectiveness in the Second-Line Setting of Metastatic Renal Cell Carcinoma

Real World Longer-Term Follow-Up Data Confirms the Effectiveness and Safety of Avelumab 1st Line Maintenance Treatment of Low-Burden Urothelial Cancer

Nordic Advisory Editorial Board*

Latest articles and MEDtalks from oncology

Follow news from congresses

MEDtalks from oncology

Breast Cancer: The Prognostic Value of Tumor-Infiltrating Lymphocytes

Prehabilitation: Making Cancer Patients Fit for Surgery and Speeding Recovery

Abemaciclib Shows Significant Benefit for HR-Positive HER2-Negative Patients with Advanced Breast Cancer

MRI-Based AI Can Detect Responsive Treatment of Breast Cancer After Three Weeks of Therapy

Maximizing the Tolerability of Enfortumab Vedotin + Pembrolizumab – The Upcoming New Standard Treatment for Advanced Bladder Cancer

Articles from oncology

ASCO 2025: Groundbreaking Data in Bladder and Prostate Cancers

LBA 18: Improvement in Survival with the Addition of Talazoparib to First-Line Enzalutamide Treatment in RR-Deficient mCRPC Patients

LBA Nordic Study: Low-Dose Aspirin Reduces Recurrence in Colorectal Cancer Patients with PI3K Pathway Mutations

ASCO GI 2025: Danish Study Highlights Efficacy and Safety of Single-Cycle Neoadjuvant Pembrolizumab for Localized dMMR Colon Cancer

ASCO GI 2025: Everolimus and Lanreotide Combo as a Breakthrough for Gastroenteropancreatic Neuroendocrine Tumors

Onkologiapäivät

Fredrik Schjesvold: Bridging Science and Clinical Innovation

Advancing Myeloma Research and Treatment: An Interview with Fredrik Schjesvold

Liposomal Daunorubicin + Cytarabine: Enhanced Synergistic Antineoplastic Effect in AML Treatment

Pulmonary Diseases in Patients with Classical Hodgkin Lymphoma

The Aquila Study Strongly Supports the Benefit of Early Intervention with Daratumumab Monotherapy in Patients with High-Risk Smoldering Multiple Myeloma

More from oncology